LRTM2 anticorps (AA 36-310) (FITC)
-
- Antigène Voir toutes LRTM2 Anticorps
- LRTM2 (Leucine-Rich Repeats and Transmembrane Domains 2 (LRTM2))
-
Épitope
- AA 36-310
- Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp LRTM2 est conjugé à/à la FITC
- Application
- Veuillez nous consulter SVP
- Réactivité croisée
- Humain
- Purification
- >95%, Protein G purified
- Immunogène
- Recombinant Human Leucine-rich repeat and transmembrane domain-containing protein 2 protein (36-310AA)
- Isotype
- IgG
- Top Product
- Discover our top product LRTM2 Anticorps primaire
-
-
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- LRTM2 (Leucine-Rich Repeats and Transmembrane Domains 2 (LRTM2))
- Autre désignation
- LRTM2 (LRTM2 Produits)
- Synonymes
- anticorps A230084J22, anticorps AI841794, anticorps leucine rich repeats and transmembrane domains 2, anticorps leucine-rich repeats and transmembrane domains 2, anticorps LRTM2, anticorps Lrtm2
- Sujet
-
Background: cytoplasm, protein kinase inhibitor activity, cytokine-mediated signaling pathway, negative regulation of JAK-STAT cascade, negative regulation of protein kinase activity.
Aliases: Leucine-rich repeat and transmembrane domain-containing protein 2 antibody, Leucine-rich repeats and transmembrane domains 2 antibody, Lrtm2 antibody, LRTM2_HUMAN antibody
- UniProt
- Q8N967
-